Multiple sclerosis with predominant, severe cognitive impairment

Archives of Neurology

Volumn 66, Issue 9, 2009, Pages 1139-1143

  Staff, Nathan P ^a   Lucchinetti, Claudia F ^a   Keegan, B Mark ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA INTERFERON; CORTICOSTEROID; GLATIRAMER; MITOXANTRONE;

ADULT; ARTICLE; BRAIN ATROPHY; CIGARETTE SMOKING; CLINICAL ARTICLE; COGNITIVE DEFECT; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE COURSE; DISEASE SEVERITY; FEMALE; HUMAN; MALE; MULTIPLE SCLEROSIS; NUCLEAR MAGNETIC RESONANCE IMAGING; ONSET AGE; PLASMAPHERESIS; PRIORITY JOURNAL; RECURRENT DISEASE; RETROSPECTIVE STUDY;

ACUTE DISEASE; ADULT; AGE OF ONSET; ATROPHY; BRAIN; CEREBELLUM; CEREBRAL CORTEX; COGNITION DISORDERS; COMORBIDITY; DISEASE PROGRESSION; FEMALE; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MULTIPLE SCLEROSIS; PHENOTYPE; SMOKING; SPINAL CORD; TIME FACTORS;

EID: 70349107686     PISSN: 00039942     EISSN: 15383687     Source Type: Journal    
DOI: 10.1001/archneurol.2009.190     Document Type: Article

References (20)

1. Rao SM. Neuropsychology of multiple sclerosis. Curr Opin Neurol. 1995;8(3):216-220.
2. Amato MP, Zipoli V, Portaccio E. Multiple sclerosis-related cognitive changes: a review of cross-sectional and longitudinal studies. J Neurol Sci. 2006;245(1-2):41-46. (Pubitemid 43775956)
3. Amato MP, Ponziani G, Pracucci G, Bracco L, Siracusa G, Amaducci L. Cognitive impairment in early-onset multiple sclerosis: pattern, predictors, and impact on everyday life in a 4-year follow-up. Arch Neurol. 1995;52(2):168-172.
4. Rao SM, Leo GJ, Ellington L, Nauertz T, Bernardin L, Unverzagt F. Cognitive dysfunction in multiple sclerosis, II: impact on employment and social functioning. Neurology. 1991;41(5):692-696.
5. Krupp LB, Christodoulou C, Melville P, Scherl WF, MacAllister WS, Elkins LE. Donepezil improved memory in multiple sclerosis in a randomized clinical trial. Neurology. 2004;63(9):1579-1585. (Pubitemid 39507572)
6. Franklin GM, Nelson LM, Filley CM, Heaton RK. Cognitive loss in multiple sclerosis: case reports and review of the literature. Arch Neurol. 1989;46(2):162-167. (Pubitemid 19051266)
7. Zarei M, Chandran S, Compston A, Hodges J. Cognitive presentation of multiple sclerosis: evidence for a cortical variant. J Neurol Neurosurg Psychiatry. 2003;74(7):872-877. (Pubitemid 36782986)
8. Polman CH, Reingold SC, Edan G, et al. Diagnostic criteria for multiple sclerosis: 2005 revisions to the "McDonald Criteria". Ann Neurol. 2005;58(6):840-846.
9. Lublin FD, Reingold SC; National Multiple Sclerosis Society (USA) Advisory Committee on Clinical Trials of New Agents in Multiple Sclerosis. Defining the clinical course of multiple sclerosis: results of an international survey. Neurology. 1996;46(4):907-911.
10. Kokmen E, Smith GE, Petersen RC, Tangalos E, Ivnik RC. The short test of mental status: correlations with standardized psychometric testing. Arch Neurol. 1991;48(7):725-728.
11. Marrie R, Horwitz R, Cutter G, Tyry T, Campagnolo D, Vollmer T. High frequency of adverse health behaviors in multiple sclerosis. Mult Scler. 2009;15(1):105-113.
12. FriendKB,MernoffST,BlockP,ReeveG.Smokingratesandsmokingcessationamong individuals with multiple sclerosis. Disabil Rehabil. 2006;28(18):1135-1141.
13. Centers for Disease Control and Prevention (CDC). Cigarette smoking among adults - United States, 2007. MMWR Morb Mortal Wkly Rep. 2008;57(45):1221-1226.
14. Riise T, Nortvedt MW, Ascherio A. Smoking is a risk factor for multiple sclerosis. Neurology. 2003;61(8):1122-1124. (Pubitemid 37461949)
15. Durfee J, Weinstock-Guttman B, Stosic J, et al. Cigarette smoking accelerates the evolution of brain atrophy and influences the severity of blood-brain-barrier disruption in multiple sclerosis. In: Proceedings from the American Academy of Neurology Annual Meeting; April 12-19, 2008; Chicago, IL.
16. Jeffery DR, Absher J, Pfeiffer FE, Jackson H. Cortical deficits in multiple sclerosis on the basis of subcortical lesions. Mult Scler. 2000;6(1):50-55. (Pubitemid 30175372)
17. Pirko I, Lucchinetti CF, Sriram S, Bakshi R. Gray matter involvement in multiple sclerosis. Neurology. 2007;68(9):634-642. (Pubitemid 46667808)
18. Bö L, Geurts JJ, van der Valk P, Polman C, Barkhof F. Lack of correlation between cortical demyelination and white matter pathologic changes in multiple sclerosis. Arch Neurol. 2007;64(1):76-80. (Pubitemid 46072427)
19. Kutzelnigg A, Lucchinetti CF, Stadelmann C, et al. Cortical demyelination and diffuse white matter injury in multiple sclerosis. Brain. 2005;128(pt 11):2705-2712. (Pubitemid 41552953)
20. Nelson F, Poonawalla AH, Hou P, Huang F, Wolinsky JS, Narayana PA. Improved identification of intracortical lesions in multiple sclerosis with phase-sensitive inversion recovery in combination with fast double inversion recovery MR imaging. AJNR Am J Neuroradiol. 2007;28(9):1645-1649. (Pubitemid 47598132)